Abstract:
The present invention relates to a composite luminophore comprising an inorganic matrix and an organic fluorescent dye, wherein the inorganic matrix is formed from an inorganic compound, and wherein the organic fluorescent dye has one or more functional groups by means of which the fluorescent dye is incorporated into the inorganic matrix, or is bound chemically thereto. The present invention further relates to a process for preparing such a composite luminophore and to the use thereof.
Abstract:
A method for the production of Mg(OH)2 nanoparticles, by means of polyol-mediated synthesis, from an Mg precursor as well as a base. The particles produced with this method have a diameter between 10 nm to 300 nm, have a mono-disperse particle distribution, and are present in non-agglomerated form. They can be converted to MgO particles by means of calcination.
Abstract:
A method for the production of Mg(OH)2 nanoparticles, by means of polyol-mediated synthesis, from an Mg precursor as well as a base. The particles produced with this method have a diameter between 10 nm to 300 nm, have a mono-disperse particle distribution, and are present in non-agglomerated form. They can be converted to MgO particles by means of calcination.
Abstract translation:通过多元醇介导的合成从Mg前体以及碱生产Mg(OH)2 N 2纳米颗粒的方法。 用该方法生产的颗粒具有10nm至300nm的直径,具有单分散颗粒分布,并且以非聚集形式存在。 它们可以通过煅烧转化为MgO颗粒。
Abstract:
The invention relates to UV emitting nanoparticles for radiation therapy purposes. If the nanoparticles are brought indirectly or directly to the diseased tissue, excitation with high energy radiation leads to VUV or UV-C emission. This UV radiation is absorbed by the surrounding organic matrix, resulting in decomposition of the material. The nanoparticles can also be modified by attaching antibodies to the particles by chemical linking or coating. Preferably these antibodies bind specifically to the cell membrane of cancer cells leading to a localised destruction of diseased tissue with a high efficacy and a lower level of destruction of surrounding healthy tissue. Endoscopic detection of the UV emission can be used as a medical imaging technique to locate and study diseased tissue.
Abstract:
A color display screen comprises a red phosphor and a color pigment having a general formula selected from the group consisting of: A1−xA′xBO2−xN1+x, where 0
Abstract:
A contrast agent for medical imaging techniques is described, comprising particles consisting of at least a core, the core comprising at least an oxide, mixed oxide, or hydroxide of specific elements. The particles optionally comprise shells containing or consisting of precious metal, radioactive isotopes, bio-compatibility agents, and/or antibodies. The applied imaging techniques comprise in particular magnetic resonance tomography (MRI), magnetic particle imaging, positron emission tomography (PET), single photon emission computed tomography (SPECT), computed tomography (CT), and ultrasound (US).
Abstract:
A gas discharge lamp fitted with a gas discharge vessel filled with a gas filling suitable for a gas discharge which emits VUV radiation, with a phosphor coating containing a down-conversion phosphor and with means for igniting and maintaining a gas discharge, in which the down-conversion phosphor has, in a host lattice, a pair of activators of a first lanthanoid ion and a second lanthanoid ion and a sensitizer selected from the group formed by the thallium(I) ion and lead(II) ion, is environmentally friendly and has a high lamp efficiency (lamp. The invention also relates to a down-conversion phosphor comprising, in a host lattice, a pair of activators of a first lanthanoid ion and a second lanthanoid ion and a sensitizer selected from the group formed by the thallium(I) ion and lead(II) ion, wherein the sensitizer occupies a crystallographic site with a coordination number C.N.≧10.
Abstract:
The invention relates to a gas discharge lamp for dielectrically impeded discharges, which gas discharge lamp is provided with a discharge vessel filled with a gas filling, which discharge vessel comprises at least a wall of a dielectric material and at least a wall having a surface which is at least partly transparent to visible radiation and coated with a phosphor layer, which phosphor layer comprises a phosphor having a host lattice, Eu2+ as the activator and a doping D selected from the group formed by Ce3+, Pr3+ and Tb3+, and provided with an electrode structure for a dielectrically impeded discharge and means for igniting and maintaining the discharge. The invention also relates to a phosphor comprising a host lattice, Eu2+ as the activator and a doping D selected from the group formed by Ce3+, Pr3+ and Tb3+.
Abstract:
A gas discharge lamp for dielectrically impeded discharges, which gas discharge lamp is provided with a discharge vessel filled with a gas filling, which discharge vessel comprises at least a wall of a dielectric material and at least a wall having a surface which is at least partly transparent to visible radiation and coated with a phosphor layer, which phosphor layer comprises a phosphor preparation of a phosphor powder and a coating, which coating comprises a compound selected from the group formed by the fluorides and orthophosphates of the elements magnesium, calcium, barium, aluminum, scandium, yttrium and lanthanum, and provided with an electrode structure for a dielectrically impeded discharge, and with means for igniting and maintaining the dielectrically impeded discharge.
Abstract:
The present invention relates to a composite luminophore comprising an inorganic matrix and an organic fluorescent dye, wherein the inorganic matrix is formed from an inorganic compound, and wherein the organic fluorescent dye has one or more functional groups by means of which the fluorescent dye is incorporated into the inorganic matrix, or is bound chemically thereto. The present invention further relates to a process for preparing such a composite luminophore and to the use thereof.